Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals

401 indexed citations

Abstract

loading...

About

This paper, published in 2015, received 401 indexed citations. Written by Andreas Theß, Stefanie Grund, Barbara L. Mui, Michael J. Hope, Patrick Baumhof, Mariola Fotin‐Mleczek and Thomas Schlake covering the research area of Molecular Biology and Genetics. It is primarily cited by scholars working on Molecular Biology (340 citations), Immunology (124 citations) and Infectious Diseases (107 citations). Published in Molecular Therapy.

Countries where authors are citing Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals

Specialization
Citations

This map shows the geographic impact of Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals more than expected).

Fields of papers citing Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals

Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Sequence-engineered mRNA Without Chemical Nucleoside Modifications Enables an Effective Protein Therapy in Large Animals.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

This paper is also available at doi.org/10.1038/mt.2015.103.

Explore hit-papers with similar magnitude of impact

Rankless by CCL
2026